Thoroughbred Financial Services, LLC Bristol Myers Squibb CO Transaction History

Thoroughbred Financial Services, LLC

$1.49 Billion
Q2 2024

A detailed history of Thoroughbred Financial Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Thoroughbred Financial Services, LLC holds 10,353 shares of BMY stock, worth $558,647. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,353

Previous 9,452 9.53%

Holding current value

$558,647

Previous $512,000 16.02%

% of portfolio

0.03%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$40.25 - $52.99 $36,265 - $47,743	901 Added 9.53%	10,353 $430,000
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $654,591 - $742,179	-13,643 Reduced 59.07%	9,452 $512,000
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $51,631 - $61,610	1,065 Added 4.83%	23,095 $1.19 Million
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $475,682 - $531,886	8,217 Added 59.49%	22,030 $1.28 Million
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $112,448 - $124,856	-1,765 Reduced 11.33%	13,813 $883,000
Q1 2023 Apr 24, 2023	BUY	$65.71 - $74.53 $61,964 - $70,281	943 Added 6.44%	15,578 $1.08 Million
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $77,998 - $92,361	1,139 Added 8.44%	14,635 $1.05 Million
Q2 2022 Aug 03, 2022	BUY	$72.62 - $79.98 $252,935 - $278,570	3,483 Added 34.78%	13,496 $1.04 Million
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $180,689 - $216,663	2,939 Added 41.55%	10,013 $731,000
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $41,134 - $47,952	-767 Reduced 9.78%	7,074 $441,000
Q3 2021 Oct 27, 2021	BUY	$59.17 - $69.31 $14,496 - $16,980	245 Added 3.23%	7,841 $463,000
Q2 2021 Jul 27, 2021	SELL	$61.91 - $67.42 $15,725 - $17,124	-254 Reduced 3.24%	7,596 $508,000
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $101,946 - $114,659	1,718 Added 28.02%	7,850 $495,000
Q4 2020 Jan 26, 2021	SELL	$57.74 - $65.43 $53,467 - $60,588	-926 Reduced 13.12%	6,132 $380,000
Q3 2020 Oct 28, 2020	BUY	$57.43 - $63.64 $5,168 - $5,727	90 Added 1.29%	7,058 $425,000
Q2 2020 Jul 20, 2020	SELL	$54.82 - $64.09 $31,466 - $36,787	-574 Reduced 7.61%	6,968 $410,000
Q1 2020 Apr 23, 2020	BUY	$46.4 - $67.43 $46 - $67	1 Added 0.01%	7,542 $420,000
Q4 2019 Feb 05, 2020	SELL	$49.21 - $64.19 $6,151 - $8,023	-125 Reduced 1.63%	7,541 $484,000
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $6,843 - $8,113	-160 Reduced 2.04%	7,666 $389,000
Q2 2019 Jul 16, 2019	SELL	$44.62 - $49.34 $15.5 Million - $17.1 Million	-347,090 Reduced 97.79%	7,826 $0
Q2 2019 Jul 16, 2019	BUY	$44.62 - $49.34 $15.4 Million - $17 Million	345,037 Added 3492.63%	354,916 $0
Q1 2019 May 07, 2019	SELL	$45.12 - $53.8 $49,541 - $59,072	-1,098 Reduced 10.0%	9,879 $471,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $535,238 - $694,075	10,977 New	10,977 $570,000

Others Institutions Holding BMY

# of Institutions

2,407

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.

Account

Thoroughbred Financial Services, LLC Bristol Myers Squibb CO Transaction History